Marshall J - Search Results

1

Using the IMEDS distributed database for epidemiological studies in type 2 diabetes mellitus.

Huang TY, Rodriguez-Watson C, Wang T, Calhoun SR, Marshall J, Burk J, Nam YH, Mendelsohn AB, Jamal-Allial A, Greenlee RT, Selvan M, Pawloski PA, McMahill Walraven CN, Rai A, Toh S, Brown JS. Huang TY, et al. Among authors: marshall j. BMJ Open Diabetes Res Care. 2022 Dec;10(6):e002916. doi: 10.1136/bmjdrc-2022-002916. BMJ Open Diabetes Res Care. 2022. PMID: 36535702 Free PMC article.

2

Safety assessment of niacin in the US Food and Drug Administration's mini-sentinel system.

Gagne JJ, Houstoun M, Reichman ME, Hampp C, Marshall JH, Toh S. Gagne JJ, et al. Among authors: marshall jh. Pharmacoepidemiol Drug Saf. 2018 Jan;27(1):30-37. doi: 10.1002/pds.4343. Epub 2017 Nov 6. Pharmacoepidemiol Drug Saf. 2018. PMID: 29108128

3

Cancer Screening Results and Follow-up Using Routinely Collected Electronic Health Data: Estimates for Breast, Colon, and Cervical Cancer Screenings.

Raman SR, Brown JS, Curtis LH, Haynes K, Marshall J, Pawloski PA, Platt R. Raman SR, et al. Among authors: marshall j. J Gen Intern Med. 2019 Mar;34(3):341-343. doi: 10.1007/s11606-018-4697-y. J Gen Intern Med. 2019. PMID: 30350029 Free PMC article. No abstract available.

4

Harnessing the Biologics and Biosimilars Collective Intelligence Consortium to Evaluate Patterns of Care.

McMahill-Walraven CN, Kent DJ, Panozzo CA, Pawloski PA, Haynes K, Marshall J, Brown J, Eichelberger B, Lockhart CM. McMahill-Walraven CN, et al. Among authors: marshall j. J Manag Care Spec Pharm. 2019 Nov;25(11):1156-1161. doi: 10.18553/jmcp.2019.19041. Epub 2019 Aug 9. J Manag Care Spec Pharm. 2019. PMID: 31397619 Free PMC article.

5

Descriptive Analysis of Long- and Intermediate-Acting Insulin and Key Safety Outcomes in Adults with Type 2 Diabetes Mellitus.

Kent DJ, McMahill-Walraven CN, Panozzo CA, Pawloski PA, Haynes K, Marshall J, Brown J, Eichelberger B, Lockhart CM. Kent DJ, et al. Among authors: marshall j. J Manag Care Spec Pharm. 2019 Nov;25(11):1162-1171. doi: 10.18553/jmcp.2019.19042. Epub 2019 Aug 12. J Manag Care Spec Pharm. 2019. PMID: 31405345 Free PMC article.

6

Capture of biologic and biosimilar dispensings in a consortium of U.S.-based claims databases: Utilization of national drug codes and Healthcare Common Procedure Coding System modifiers in medical claims.

Zhang J, Haynes K, Mendelsohn AB, Marshall J, Barr CE, McDermott C, Brown J, Kline A, Kenney J, King KJ, Holmes C, Yeung K, Barron J, Yun H, Lockhart CM. Zhang J, et al. Among authors: marshall j. Pharmacoepidemiol Drug Saf. 2020 Jul;29(7):778-785. doi: 10.1002/pds.4934. Epub 2019 Dec 4. Pharmacoepidemiol Drug Saf. 2020. PMID: 31802568

7

Incidence of statin use in older adults with and without cardiovascular disease and diabetes mellitus, January 2008- March 2018.

Panozzo CA, Curtis LH, Marshall J, Fine L, Wells BL, Brown JS, Haynes K, Pawloski PA, Hernandez AF, Malek S, Syat B, Platt R. Panozzo CA, et al. Among authors: marshall j. PLoS One. 2019 Dec 5;14(12):e0223515. doi: 10.1371/journal.pone.0223515. eCollection 2019. PLoS One. 2019. PMID: 31805056 Free PMC article.

8

Mapping from the International Classification of Diseases (ICD) 9th to 10th Revision for Research in Biologics and Biosimilars Using Administrative Healthcare Data.

He M, Santiago Ortiz AJ, Marshall J, Mendelsohn AB, Curtis JR, Barr CE, Lockhart CM, Kim SC. He M, et al. Among authors: marshall j. Pharmacoepidemiol Drug Saf. 2020 Jul;29(7):770-777. doi: 10.1002/pds.4933. Epub 2019 Dec 18. Pharmacoepidemiol Drug Saf. 2020. PMID: 31854053

9

Incidence of Serious Infections and Design of Utilization and Safety Studies for Biologic and Biosimilar Surveillance.

Zhang J, Sridhar G, Barr CE, Eichelberger B, Lockhart CM, Marshall J, Clewell J, Accortt NA, Curtis JR, Holmes C, McMahill-Walraven CN, Brown JS, Haynes K. Zhang J, et al. Among authors: marshall j. J Manag Care Spec Pharm. 2020 Apr;26(4):417-490. doi: 10.18553/jmcp.2020.26.4.417. J Manag Care Spec Pharm. 2020. PMID: 32223608 Free PMC article.

10

Utilization patterns and characteristics of users of biologic anti-inflammatory agents in a large, US commercially insured population.

Mendelsohn AB, Nam YH, Marshall J, McDermott CL, Kochar B, Kappelman MD, Brown JS, Lockhart CM. Mendelsohn AB, et al. Among authors: marshall j. Pharmacol Res Perspect. 2021 Feb;9(1):e00708. doi: 10.1002/prp2.708. Pharmacol Res Perspect. 2021. PMID: 33372729 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,937 results

Search Page